Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy?-Reference-Cited by-同舟云学术

Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy?

Published:2019-08 Issue: Volume:46 Page:52-57
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Lee Clara I.,Fox Peter,Balakrishnar Bavanthi,Balleine Rosemary L.,Gao Bo,Provan Pamela,Coulter Sally,Liddle Christopher,Hui Rina,Wong Mark,Gurney Howard,Wilcken Nicholas

Funder

Australian National Health and Medical Research Council

Pharmacogenomics Research for Individualised Medicine

Sydney West Translational Cancer Research Centre

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference23 articles.

1. Tamoxifen, hot flashes and recurrence in breast cancer;Mortimer;Breast Canc Res Treat,2008

2. Adherence and discontinuation of oral hormonal therapy in patients with hormone receptor positive breast cancer;Ayres;Int J Clin Pharm,2014

3. Clinical and biomarker predictors of side effects from tamoxifen;Lorizio;Breast Canc Res Treat,2012

4. Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes;Goetz;J Clin Oncol,2005

5. Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial;Cuzick;Lancet Oncol,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects?;Drugs;2024-03-14

2. The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancer;ESMO Open;2023-02

3. Value of therapeutic drug monitoring of endoxifen in Egyptian premenopausal patients with breast cancer given tamoxifen adjuvant therapy: A pilot study;Journal of Oncology Pharmacy Practice;2022-12-25

4. Association of single nucleotide polymorphisms of cytochrome P450 enzymes with experience of vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients: a systematic review;BMC Cancer;2021-05-18

5. Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive Disease;Clinical Cancer Research;2021-02-19